Jeffery D. Esko, Ph.D.
Co-founder and Chief Scientific Advisor’
Dr. Esko is currently a Professor at the Department of Cellular and Molecular Medicine at University of California at San Diego.
Dr. Esko’s pioneering approach using mutant cells in his lab at the University of Alabama, Birmingham (1983-1996) and then later using genetically altered mice at the University of California, San Diego has helped bring to light many key functions played by glycans and has lead to over 100 publications, a March of Dimes Basil O’Connor Award (1984 -1986), a 10 year NIH MERIT award in 1999 and the Karl Meyer award in 2007. At UCSD, Dr. Esko’s lab continues to be a leader in the field of glycobiology. He also co-directs the Glycobiology Research and Training Center. Dr. Esko was President of the Society for Glycobiology in 2002-2003.
Dr. Esko recognized the importance of glycans as drug targets early on and served on the Scientific Advisory Board for one of the original glycobiology biotech companies, Glycomed (1990 – 1995). Since then he has had continuous demand for his expertise in glycobiology and has consulted for a number of biotechnology and pharmaceutical companies. Technology developed by Dr. Esko has opened the glycobiology field to modern drug discovery. Dr. Esko received his Ph.D. from the University of Wisconsin, Madison.
|
